Phenylalanyl-tRNA synthetase, PheRS, the target of anti-Zo autoantibodies, has been linked to cancer by reports of increased expression in some cancers (128–130), and suggested to be a prognostic indicator for some cancers (131). This evidence concerns the gene FARS2 and cancer.